Literature DB >> 10476753

Clinical characteristics of Chlamydia pneumoniae infection as the sole cause of community-acquired pneumonia.

T M File1, J F Plouffe, R F Breiman, S K Skelton.   

Abstract

The clinical characteristics of 26 patients with community-acquired pneumonia due to Chlamydia pneumoniae as the only identified pathogen who required hospitalization were evaluated. Most patients (18) had reinfection based on serological results. The mean age of the patients was 55 years (38 years, patients with primary infection; 63 years, patients with reinfection), and the gender representation was equal. Generally, illness was mild and associated with limited temperature elevation and nonspecific symptoms. The presence of comorbid illnesses and the requirement of supplemental oxygen therapy were the most common criteria for hospital admission.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10476753     DOI: 10.1086/520227

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  10 in total

1.  BTS Guidelines for the Management of Community Acquired Pneumonia in Adults.

Authors: 
Journal:  Thorax       Date:  2001-12       Impact factor: 9.139

2.  Community epidemiology of Chlamydia and Mycoplasma pneumoniae in LRTI in France over 29 months.

Authors:  Jacques Gaillat; Antoine Flahault; Bertille deBarbeyrac; Jeanne Orfila; Henri Portier; Jean-Pierre Ducroix; Christiane Bébéar; Charles Mayaud
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

3.  Investigation of a Chlamydia pneumoniae outbreak in a Federal correctional facility in Texas.

Authors:  Laura Conklin; Jennifer Adjemian; Jennifer Loo; Sema Mandal; Carol Davis; Sharyn Parks; Tina Parsons; Brian McDonough; Jorge Partida; Kathleen Thurman; Maureen H Diaz; Alvaro Benitez; Tracy Pondo; Cynthia G Whitney; Jonas M Winchell; Newton Kendig; Chris Van Beneden
Journal:  Clin Infect Dis       Date:  2013-05-30       Impact factor: 9.079

4.  Effectiveness of beta lactam antibiotics compared with antibiotics active against atypical pathogens in non-severe community acquired pneumonia: meta-analysis.

Authors:  Graham D Mills; Michael R Oehley; Bruce Arrol
Journal:  BMJ       Date:  2005-01-31

5.  Atypical pathogens as etiologic agents in hospitalized patients with community-acquired pneumonia in Korea: a prospective multi-center study.

Authors:  Jang Wook Sohn; Seung Chul Park; Young-Hwa Choi; Heung Jeong Woo; Yong Kyun Cho; Jin Soo Lee; Hee-Sun Sim; Min Ja Kim
Journal:  J Korean Med Sci       Date:  2006-08       Impact factor: 2.153

6.  Successful treatment of Chlamydophila pneumoniae acute respiratory distress syndrome with extracorporeal membrane oxygenator: a case report and diagnostic review.

Authors:  David De Bels; Philippe Gottignies; Marijke Reynders; Sébastien Roques; Stephan Wilmin; Véronique-Yvette Miendje Deyi; Sophie Jamart; Jacques Devriendt
Journal:  J Med Case Rep       Date:  2012-01-17

Review 7.  Antimicrobial therapy of community-acquired pneumonia.

Authors:  Thomas M File; Michael S Niederman
Journal:  Infect Dis Clin North Am       Date:  2004-12       Impact factor: 5.982

Review 8.  Re-evaluation of the therapy of severe pneumonia caused by Streptococcus pneumoniae.

Authors:  Joseph F Plouffe; Daniel R Martin
Journal:  Infect Dis Clin North Am       Date:  2004-12       Impact factor: 5.982

Review 9.  Empiric treatment of ambulatory community-acquired pneumonia: always include treatment for atypical agents.

Authors:  Thomas J Marrie
Journal:  Infect Dis Clin North Am       Date:  2004-12       Impact factor: 5.982

Review 10.  Community-acquired pneumonia.

Authors:  Thomas M File
Journal:  Lancet       Date:  2003-12-13       Impact factor: 79.321

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.